Inactive Instrument
Sector Signal Genetics Inc Nasdaq
Stocks
US8266401046
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-31 | Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push | RE |
| 08-07 | Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.97% | -0.75% | +3.77% | +17.53% | +8.48% | +3.51% | +18.46% | -24.92% | +211.15% | 49.74B | |
| -0.30% | -2.88% | +11.57% | +38.28% | +162.69% | +429.29% | +496.95% | +601.64% | - | 44.98B | |
| +2.13% | +0.89% | +12.26% | +46.06% | +17.05% | +43.59% | +17.61% | -0.52% | +242.83% | 42.52B | |
| +0.87% | -3.73% | +14.48% | +31.70% | +19.08% | +8.96% | +73.17% | +8.64% | +1,126.79% | 40.78B | |
| -0.90% | -3.67% | -0.21% | +4.11% | +8.07% | +14.26% | +48.44% | -21.32% | +143.00% | 32.89B | |
| +2.71% | +6.82% | +9.59% | +23.41% | - | - | - | - | - | 17.09B | |
| +1.68% | -4.20% | +2.76% | +33.09% | +5.59% | +25.28% | +116.83% | +205.82% | +1,831.66% | 16.28B | |
| +1.70% | -0.05% | +6.78% | +18.65% | +16.63% | +18.53% | +28.50% | -40.97% | +96.09% | 14.4B | |
| +3.34% | -1.13% | +25.48% | +66.92% | +46.26% | +80.94% | +39.19% | -35.03% | +245.61% | 13.48B | |
| -0.97% | -5.38% | -2.28% | +16.21% | -12.28% | -10.12% | -39.15% | -38.82% | +107.21% | 12.45B | |
| -0.53% | -9.55% | +41.19% | +24.83% | +4.89% | -20.93% | - | - | - | 11.24B | |
| +0.17% | -0.11% | +0.29% | +45.27% | +22.94% | +35.34% | -8.20% | -43.38% | +170.58% | 11.32B | |
| -1.29% | -4.82% | +14.27% | +74.92% | +47.91% | +32.94% | +42.83% | -47.38% | - | 10.64B | |
| -1.83% | -3.74% | -9.08% | +53.17% | -19.73% | +40.07% | +463.23% | +200.16% | +2,353.05% | 10.68B | |
| -0.01% | +0.09% | +0.73% | +71.60% | +78.95% | +256.76% | +446.62% | - | - | 10.19B | |
| +2.42% | -3.20% | +18.47% | -15.95% | -22.48% | +6.68% | +51.43% | +51.25% | +108.18% | 9.95B | |
| -0.35% | -5.51% | +14.73% | +66.40% | +52.46% | +191.55% | +497.33% | +95.47% | - | 9.9B | |
| +1.15% | -5.27% | +16.14% | +38.52% | +21.29% | +695.51% | +1,418.05% | +13.49% | - | 9.87B | |
| -0.28% | -3.58% | +6.91% | +56.69% | +67.25% | +148.22% | +647.59% | +194.40% | +1,109.27% | 9.48B | |
| Average | +0.56% | -2.70% | +9.89% | +37.44% | +29.17% | +111.13% | +256.40% | +69.91% | +645.45% | 19.89B | |
| Weighted average by Cap. | +0.67% | -2.41% | +9.31% | +33.33% | +35.68% | +104.24% | +189.89% | +93.80% | +553.00% |
- Stock Market
- Stocks
- VRDN Stock
- Stock
- Sector Signal Genetics Inc
Select your edition
All financial news and data tailored to specific country editions
